vs
纽约时报公司（NYT）与瑞思迈（RMD）财务数据对比。点击上方公司名可切换其他公司
瑞思迈的季度营收约是纽约时报公司的1.8倍（$1.4B vs $802.3M），瑞思迈净利率更高（27.6% vs 16.2%，领先11.4%），瑞思迈同比增速更快（11.0% vs 10.4%），过去两年纽约时报公司的营收复合增速更高（16.2% vs 7.8%）
纽约时报公司是美国知名大众传媒企业，总部位于纽约市曼哈顿的纽约时报大厦，旗下核心出版产品包括《纽约时报》及其国际版等系列刊物，同时运营多元媒体资产，在全球新闻传媒领域拥有较高知名度。
瑞思迈是一家起源于澳大利亚、总部位于美国加利福尼亚州圣迭戈的医疗设备企业，主打可接入云端的呼吸类医疗设备，用于治疗睡眠呼吸暂停、慢性阻塞性肺病等呼吸道疾病，新冠疫情期间曾大量生产呼吸机等设备助力患者救治。
NYT vs RMD — 直观对比
营收规模更大
RMD
是对方的1.8倍
$802.3M
营收增速更快
RMD
高出0.6%
10.4%
净利率更高
RMD
高出11.4%
16.2%
两年增速更快
NYT
近两年复合增速
7.8%
损益表 — Q4 FY2025 vs Q4 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $802.3M | $1.4B |
| 净利润 | $129.8M | $392.6M |
| 毛利率 | — | 61.8% |
| 营业利润率 | 20.1% | 34.6% |
| 净利率 | 16.2% | 27.6% |
| 营收同比 | 10.4% | 11.0% |
| 净利润同比 | 4.9% | 13.9% |
| 每股收益（稀释后） | $0.79 | $2.68 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收NYTRMD
| Q2 26 | — | $1.4B | ||
| Q1 26 | — | $1.4B | ||
| Q4 25 | $802.3M | $1.4B | ||
| Q3 25 | $700.8M | $1.3B | ||
| Q2 25 | $685.9M | $1.3B | ||
| Q1 25 | $635.9M | $1.3B | ||
| Q4 24 | $726.6M | $1.3B | ||
| Q3 24 | $640.2M | $1.2B |
净利润NYTRMD
| Q2 26 | — | $392.6M | ||
| Q1 26 | — | $398.7M | ||
| Q4 25 | $129.8M | $392.6M | ||
| Q3 25 | $81.6M | $348.5M | ||
| Q2 25 | $82.9M | $379.7M | ||
| Q1 25 | $49.6M | $365.0M | ||
| Q4 24 | $123.7M | $344.6M | ||
| Q3 24 | $64.1M | $311.4M |
毛利率NYTRMD
| Q2 26 | — | 61.8% | ||
| Q1 26 | — | 62.2% | ||
| Q4 25 | — | 61.8% | ||
| Q3 25 | — | 61.5% | ||
| Q2 25 | — | 60.8% | ||
| Q1 25 | — | 59.3% | ||
| Q4 24 | — | 58.6% | ||
| Q3 24 | — | 58.6% |
营业利润率NYTRMD
| Q2 26 | — | 34.6% | ||
| Q1 26 | — | 34.9% | ||
| Q4 25 | 20.1% | 34.6% | ||
| Q3 25 | 15.0% | 33.4% | ||
| Q2 25 | 15.5% | 33.7% | ||
| Q1 25 | 9.2% | 33.0% | ||
| Q4 24 | 20.2% | 32.5% | ||
| Q3 24 | 12.0% | 31.6% |
净利率NYTRMD
| Q2 26 | — | 27.6% | ||
| Q1 26 | — | 27.9% | ||
| Q4 25 | 16.2% | 27.6% | ||
| Q3 25 | 11.7% | 26.1% | ||
| Q2 25 | 12.1% | 28.2% | ||
| Q1 25 | 7.8% | 28.3% | ||
| Q4 24 | 17.0% | 26.9% | ||
| Q3 24 | 10.0% | 25.4% |
每股收益（稀释后）NYTRMD
| Q2 26 | — | $2.68 | ||
| Q1 26 | — | $2.74 | ||
| Q4 25 | $0.79 | $2.68 | ||
| Q3 25 | $0.50 | $2.37 | ||
| Q2 25 | $0.50 | $2.58 | ||
| Q1 25 | $0.30 | $2.48 | ||
| Q4 24 | $0.74 | $2.34 | ||
| Q3 24 | $0.39 | $2.11 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $642.2M | $1.4B |
| 总债务越低越好 | — | $663.8M |
| 股东权益账面价值 | $2.0B | $6.3B |
| 总资产 | $3.0B | $8.5B |
| 负债/权益比越低杠杆越低 | — | 0.11× |
8季度趋势，按日历期对齐
现金及短期投资NYTRMD
| Q2 26 | — | $1.4B | ||
| Q1 26 | — | $1.7B | ||
| Q4 25 | $642.2M | $1.4B | ||
| Q3 25 | $617.4M | $1.4B | ||
| Q2 25 | $540.2M | $1.2B | ||
| Q1 25 | $522.1M | $932.7M | ||
| Q4 24 | $565.9M | $521.9M | ||
| Q3 24 | $492.9M | $426.4M |
总债务NYTRMD
| Q2 26 | — | $663.8M | ||
| Q1 26 | — | $664.1M | ||
| Q4 25 | — | $403.9M | ||
| Q3 25 | — | $408.7M | ||
| Q2 25 | — | $658.4M | ||
| Q1 25 | — | $663.1M | ||
| Q4 24 | — | $662.9M | ||
| Q3 24 | — | $667.6M |
股东权益NYTRMD
| Q2 26 | — | $6.3B | ||
| Q1 26 | — | $6.5B | ||
| Q4 25 | $2.0B | $6.3B | ||
| Q3 25 | $2.0B | $6.1B | ||
| Q2 25 | $1.9B | $6.0B | ||
| Q1 25 | $1.9B | $5.5B | ||
| Q4 24 | $1.9B | $5.3B | ||
| Q3 24 | $1.9B | $5.2B |
总资产NYTRMD
| Q2 26 | — | $8.5B | ||
| Q1 26 | — | $8.8B | ||
| Q4 25 | $3.0B | $8.5B | ||
| Q3 25 | $2.9B | $8.3B | ||
| Q2 25 | $2.8B | $8.2B | ||
| Q1 25 | $2.7B | $7.6B | ||
| Q4 24 | $2.8B | $7.1B | ||
| Q3 24 | $2.8B | $7.2B |
负债/权益比NYTRMD
| Q2 26 | — | 0.11× | ||
| Q1 26 | — | 0.10× | ||
| Q4 25 | — | 0.06× | ||
| Q3 25 | — | 0.07× | ||
| Q2 25 | — | 0.11× | ||
| Q1 25 | — | 0.12× | ||
| Q4 24 | — | 0.13× | ||
| Q3 24 | — | 0.13× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $164.2M | — |
| 自由现金流经营现金流 - 资本支出 | $157.6M | — |
| 自由现金流率自由现金流/营收 | 19.6% | — |
| 资本支出强度资本支出/营收 | 0.8% | — |
| 现金转化率经营现金流/净利润 | 1.26× | — |
| 过去12个月自由现金流最近4个季度 | $550.5M | — |
8季度趋势，按日历期对齐
经营现金流NYTRMD
| Q2 26 | — | — | ||
| Q1 26 | — | — | ||
| Q4 25 | $164.2M | $339.7M | ||
| Q3 25 | $207.6M | $457.3M | ||
| Q2 25 | $113.6M | $538.8M | ||
| Q1 25 | $99.1M | $578.7M | ||
| Q4 24 | $151.7M | $308.6M | ||
| Q3 24 | $125.5M | $325.5M |
自由现金流NYTRMD
| Q2 26 | — | — | ||
| Q1 26 | — | — | ||
| Q4 25 | $157.6M | $311.2M | ||
| Q3 25 | $199.7M | $414.4M | ||
| Q2 25 | $103.3M | $508.2M | ||
| Q1 25 | $89.9M | $557.9M | ||
| Q4 24 | $143.6M | $288.0M | ||
| Q3 24 | $118.4M | $307.7M |
自由现金流率NYTRMD
| Q2 26 | — | — | ||
| Q1 26 | — | — | ||
| Q4 25 | 19.6% | 21.9% | ||
| Q3 25 | 28.5% | 31.0% | ||
| Q2 25 | 15.1% | 37.7% | ||
| Q1 25 | 14.1% | 43.2% | ||
| Q4 24 | 19.8% | 22.5% | ||
| Q3 24 | 18.5% | 25.1% |
资本支出强度NYTRMD
| Q2 26 | — | — | ||
| Q1 26 | — | — | ||
| Q4 25 | 0.8% | 2.0% | ||
| Q3 25 | 1.1% | 3.2% | ||
| Q2 25 | 1.5% | 2.3% | ||
| Q1 25 | 1.5% | 1.6% | ||
| Q4 24 | 1.1% | 1.6% | ||
| Q3 24 | 1.1% | 1.5% |
现金转化率NYTRMD
| Q2 26 | — | — | ||
| Q1 26 | — | — | ||
| Q4 25 | 1.26× | 0.87× | ||
| Q3 25 | 2.54× | 1.31× | ||
| Q2 25 | 1.37× | 1.42× | ||
| Q1 25 | 2.00× | 1.59× | ||
| Q4 24 | 1.23× | 0.90× | ||
| Q3 24 | 1.96× | 1.05× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
NYT
| Subscription | $510.5M | 64% |
| Advertising | $191.7M | 24% |
| Affiliate Licensing And Other Products And Services | $100.2M | 12% |
RMD
暂无分部数据
